BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20502051)

  • 1. The immunosuppressive drug mizoribine directly prevents podocyte injury in puromycin aminonucleoside nephrosis.
    Takeuchi S; Hiromura K; Tomioka M; Takahashi S; Sakairi T; Maeshima A; Kaneko Y; Kuroiwa T; Nojima Y
    Nephron Exp Nephrol; 2010; 116(1):e3-10. PubMed ID: 20502051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mizoribine reduces urinary protein excretion in rats given puromycin aminonucleoside.
    Shibasaki T; Matsuda H; Gomi H; Usui M; Ishimoto F; Sakai O
    Am J Nephrol; 1996; 16(2):167-72. PubMed ID: 8919236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenomedullin ameliorates podocyte injury induced by puromycin aminonucleoside in vitro and in vivo through modulation of Rho GTPases.
    Dong N; Meng L; Xue R; Yu M; Zhao Z; Liu X
    Int Urol Nephrol; 2017 Aug; 49(8):1489-1506. PubMed ID: 28528353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats.
    Okada T; Sakaguchi T; Hatamura I; Saji F; Negi S; Otani H; Muragaki Y; Kawachi H; Shigematsu T
    Clin Exp Nephrol; 2009 Oct; 13(5):438-446. PubMed ID: 19452240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluvastatin ameliorates podocyte injury in proteinuric rats via modulation of excessive Rho signaling.
    Shibata S; Nagase M; Fujita T
    J Am Soc Nephrol; 2006 Mar; 17(3):754-64. PubMed ID: 16452496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mizoribine in the treatment of pediatric-onset glomerular disease.
    Tanaka H; Tsuruga K; Imaizumi T
    World J Pediatr; 2015 May; 11(2):108-12. PubMed ID: 25754750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of absolute amount of nephrin in a single podocyte in puromycin aminonucleoside nephrosis rats calculated by quantitative glomerular proteomics approach with selected reaction monitoring mode.
    Kawakami H; Kamiie J; Yasuno K; Kobayashi R; Aihara N; Shirota K
    Nephrol Dial Transplant; 2012 Apr; 27(4):1324-30. PubMed ID: 21862459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of cyclosporin on podocyte ZO-1 expression in puromycin aminonucleoside nephrosis rats.
    Kim BS; Park HC; Kang SW; Choi KH; Ha SK; Han DS; Lee HY
    Yonsei Med J; 2005 Feb; 46(1):141-8. PubMed ID: 15744817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triptolide protects podocytes from puromycin aminonucleoside induced injury in vivo and in vitro.
    Zheng CX; Chen ZH; Zeng CH; Qin WS; Li LS; Liu ZH
    Kidney Int; 2008 Sep; 74(5):596-612. PubMed ID: 18509322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active vitamin D and its analogue, 22-oxacalcitriol, ameliorate puromycin aminonucleoside-induced nephrosis in rats.
    Matsui I; Hamano T; Tomida K; Inoue K; Takabatake Y; Nagasawa Y; Kawada N; Ito T; Kawachi H; Rakugi H; Imai E; Isaka Y
    Nephrol Dial Transplant; 2009 Aug; 24(8):2354-61. PubMed ID: 19297354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicorandil protects podocytes via modulation of antioxidative capacity in acute puromycin aminonucleoside-induced nephrosis in rats.
    Yamanaka M; Tamura Y; Kuribayashi-Okuma E; Uchida S; Shibata S
    Am J Physiol Renal Physiol; 2023 Feb; 324(2):F168-F178. PubMed ID: 36454699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mizoribine corrects defective nephrin biogenesis by restoring intracellular energy balance.
    Nakajo A; Khoshnoodi J; Takenaka H; Hagiwara E; Watanabe T; Kawakami H; Kurayama R; Sekine Y; Bessho F; Takahashi S; Swiatecka-Urban A; Tryggvason K; Yan K
    J Am Soc Nephrol; 2007 Sep; 18(9):2554-64. PubMed ID: 17687078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.
    Koshikawa M; Mukoyama M; Mori K; Suganami T; Sawai K; Yoshioka T; Nagae T; Yokoi H; Kawachi H; Shimizu F; Sugawara A; Nakao K
    J Am Soc Nephrol; 2005 Sep; 16(9):2690-701. PubMed ID: 15987752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Puromycin aminonucleoside increases podocyte permeability by modulating ZO-1 in an oxidative stress-dependent manner.
    Ha TS; Park HY; Seong SB; Ahn HY
    Exp Cell Res; 2016 Jan; 340(1):139-49. PubMed ID: 26683996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,25-Dihydroxyvitamin D(3) prevents puromycin aminonucleoside-induced apoptosis of glomerular podocytes by activating the phosphatidylinositol 3-kinase/Akt-signaling pathway.
    Xiao H; Shi W; Liu S; Wang W; Zhang B; Zhang Y; Xu L; Liang X; Liang Y
    Am J Nephrol; 2009; 30(1):34-43. PubMed ID: 19202327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of nestin protects podocytes from apoptosis induced by puromycin aminonucleoside.
    Wen D; You L; Zhang Q; Zhang L; Gu Y; Hao CM; Chen J
    Am J Nephrol; 2011; 34(5):423-34. PubMed ID: 21952051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Podocyte injury is suppressed by 1,25-dihydroxyvitamin D via modulation of transforming growth factor-beta 1/bone morphogenetic protein-7 signalling in puromycin aminonucleoside nephropathy rats.
    Xiao HQ; Shi W; Liu SX; Zhang B; Xu LX; Liang XL; Liang YZ
    Clin Exp Pharmacol Physiol; 2009 Jul; 36(7):682-9. PubMed ID: 19594554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoids as a potential treatment for experimental puromycin-induced nephrosis.
    Moreno-Manzano V; Mampaso F; Sepúlveda-Muñoz JC; Alique M; Chen S; Ziyadeh FN; Iglesias-de la Cruz MC; Rodríguez J; Nieto E; Orellana JM; Reyes P; Arribas I; Xu Q; Kitamura M; Lucio Cazana FJ
    Br J Pharmacol; 2003 Jun; 139(4):823-31. PubMed ID: 12813006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bone mesenchymal stem cell transplantation repairs glomerular podocytes in rats with puromycin aminonucleoside-induced nephrosis].
    Yang HD; Dong C; Guan FJ; Gao LL; Zhao T; Feng BF
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jun; 12(6):483-7. PubMed ID: 20540862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of alpha(3) integrin-mediated podocyte shape by superoxide dismutase in the puromycin aminonucleoside nephrosis rat.
    Kojima K; Matsui K; Nagase M
    Am J Kidney Dis; 2000 Jun; 35(6):1175-85. PubMed ID: 10845833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.